Similarly, in a clinical trial known as “IL-6 Inhibition for Modulating Inflammation After Cardiac Arrest” (IMICA), 80 comatose patients with out-of-hospital cardiac arrests were randomly assigned to a single infusion of tocilizumab versus placebo [23]. The gene discussed is IL6; the disease is cardiac arrest.